Clin2
NCT06040268Possibly a fitRecruiting

Advair study for HAPE risk and healthy volunteers

Altitude Edema

Part of Lungs & breathing clinical trials.

This trial tests if Advair HFA affects how likely someone is to develop High Altitude Pulmonary Edema (HAPE), a serious lung condition at high altitudes. It compares people who are prone to HAPE, those who are resistant, and healthy controls.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
60 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You are between 18 and 50 years old
  • Your BMI is between 20 and 35
  • You are in good general health with no major medical issues
  • For HAPE-prone group: you have had a documented episode of HAPE at high altitude and live below 3,000 feet
  • For HAPE-resistant group: you have traveled to high altitude without getting HAPE and live below 3,000 feet
  • For healthy controls: you are a Colorado resident

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07431554Recruiting
Studying heart function in low oxygen after HAPE

This study looks at how the right side of the heart responds to low oxygen levels in people who have had high altitude pulmonary edema (HAPE) in the past. It will help researchers better understand right heart function.

Zurich
NCT07536477Recruiting
High-flow oxygen versus standard oxygen for altitude lung swelling

This trial tests whether high-flow oxygen (delivered through a special nasal tube) works better than standard oxygen therapy for a condition called high-altitude pulmonary edema (HAPE)—fluid buildup in the lungs caused by rapid ascent to high altitude. The study aims to see which approach helps patients breathe better and recover faster.

Xigazê, Tibet
NCT07639931Not yet recruiting
Treatment for severe altitude sickness

This trial tests new ways to diagnose and treat severe altitude sickness, which can cause fluid in the lungs or swelling in the brain. It aims to improve care for people who get very sick after climbing to high altitudes quickly.

Lhasa, Tibet
NCT06852924Recruiting
Inhaled nitric oxide for HAPE treatment trial

This trial tests if inhaled nitric oxide helps people with high-altitude pulmonary edema (fluid in the lungs from high altitude). It may offer a new treatment option for those with mild to moderate symptoms.

Lhasa, Tibet
NCT07600086Not yet recruiting
Study of high-altitude polycythemia

This study looks at high-altitude polycythemia, a condition where your body makes too many red blood cells because of living at high altitude. Researchers want to learn more about it, so they are inviting people with this condition to participate.

Xizang
NCT07804693Not yet recruiting
Pulmonary hypertension study at high altitude

This study looks at how the heart and lungs respond when people with pulmonary hypertension travel from low to high altitude. It may help doctors understand how to better care for patients living at high altitudes.

Zurich

Hear when a new Altitude Edema trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.